Cathie Wood sells $19 million of surging tech stocks before earnings
Cathie Wood, chief of Ark Investment Management, believes in tech stocks that will have a “disruptive” impact in the future. She often trims her stakes to lock up profits. Sometimes, her strategy works: The flagship ARK Innovation ETF (ARKK) has returned 10.
Cathie Wood buys $16.6 million of wavering tech stocks
Cathie Wood, chief of Ark Investment Management, believes in tech stocks that will have a disruptive impact. She isn’t afraid to buy them on the way down — or up. Sometimes her strategy works: The flagship Ark Innovation ETF (ARKK) has returned 9% this year as of Jan.
Cathie Wood’s ARK Investment buys 370K shares of 10x Genomics today
EST Cathie Wood’s ARK Investment buys 370K shares of 10x Genomics (TXG) todayInvest with Confidence: Follow TipRanks' Top Wall Street
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
The aggressive growth investor was buying stocks moving in different directions on the first trading day of the week.
Cathie Wood unloads $11.8 million in two high-tech defense stocks
However, not all investors are persuaded by Wood's confidence. Over the past year, the ARK Innovation ETF has seen a net outflow of $3 billion, with $320 million exiting the fund in the past month, according to ETF research firm VettaFi.
Cathie Wood’s ARK Investment buys 172K shares of Teradyne today
EST Cathie Wood’s ARK Investment buys 172K shares of Teradyne (TER) todayInvest with Confidence: Follow TipRanks' Top Wall Street
Cathie Wood's Ark Invest Offloads 375,000 Palantir Shares in January
ARKK, the flagship fund of Ark Invest, has removed 187,968 shares of Palantir Technologies throughout January 2022. PLTR continues to be ARKK's fifth-largest holding with a market value at $351.9 million while representing 5.
Cathie Wood's ARK ETF Buys CRISPR, Sells Roblox and Accolade Stock
Cathie Wood's ARK ETFs published their daily trades for Friday, January 31st, 2025, with a notable emphasis on the biotech sector. Leading the charge in purchases was CRISPR Therapeutics AG (NASDAQ:CRSP),
Cathie Wood's ARK shifts focus, sells Adyen, buys Teradyne stock
Cathie Wood's ARK ETFs have made their daily trades for Thursday, January 30th, 2025, with a notable pivot in their investment strategy. The funds executed a series of buys and sells across various sectors,
Cathie Wood's Ark Invest Dumps Over $10 Million Worth Of Palantir Stock As AI Competition Heats Up
Jan. 30, 2025 Cathie Wood-led Ark Invest sold $10.4 million worth of Palantir shares through its flagship fund.
Cathie Wood Says Software Is the Next Big AI Opportunity -- 2 Ark ETFs You'll Want to Buy if She's Right
Cathie Wood is one of the most vocal bulls on Wall Street when it comes to the potential of artificial intelligence (AI).
24/7 Wall St. on MSN5d
Cathie Wood Just Bought 5 Million Shares of This High-Flying Innovator
Cathie Wood, the woman behind the scenes over at Ark Invest, is still taking a proactive approach to play what she believes ...
Cathie Wood's Ark Invest Bets On Biotech With CRISPR Therapeutics Investment, Exits Roblox
Cathie Wood-led Ark Invest made significant trades involving CRSP, TXG, RBLX, ACHR, NU, ADYEY, ACCD, and AVAV.
Cathie Wood won’t invest in Trump coin, will stick to the ‘big three’
Cathie Wood, CEO of ARK Invest, said she won’t buy Trump coin, calling it a memecoin without utility. Her focus remains on ...
Bloomberg Talks: Cathie Wood on DeepSeek
Cathie Wood, head of ARK Investment Management, usually targets tech stocks that she says have a disruptive impact, even if ...